Gts Securities LLC Revance Therapeutics, Inc. Transaction History
Gts Securities LLC
- $46.5 Billion
- Q2 2024
A detailed history of Gts Securities LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 12,600 shares of RVNC stock, worth $32,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,600
Previous 34,600
63.58%
Holding current value
$32,381
Previous $170,000
81.18%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVNC
# of Institutions
196Shares Held
81.5MCall Options Held
490KPut Options Held
128K-
Capital World Investors Los Angeles, CA13.9MShares$35.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.26MShares$16.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$15.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.26MShares$13.5 Million1.71% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...